Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice

Yasunori Matsumoto, Shinji Miwa, Yong Zhang, Ming Zhao, Shuuya Yano, Fuminari Uehara, Mako Yamamoto, Yukihiko Hiroshima, Makoto Toneri, Michael Bouvet, Hisahiro Matsubara, Hiroyuki Tsuchiya, Robert M. Hoffman

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Peritoneal disseminated cancer is highly treatment resistant. We here report the efficacy of intraperitoneal (i.p.) administration of tumor-targeting Salmonella typhimurium A1-R in a nude mouse model of disseminated human ovarian cancer. The mouse model was established by intraperitoneal injection of the human ovarian cancer cell line SKOV3-GFP. Seven days after implantation, mice were treated with S. typhimurium A1-R via intravenous (i.v.) or i.p. administration at the same dose, 5×107 CFU, once per week. Both i.v. and i.p. treatments effected prolonged survival compared with the untreated control group (P=0.025 and P<0.001, respectively). However, i.p. treatment was less toxic than i.v. treatment. Tumor-specific targeting of S. typhimurium A1-R was confirmed with bacterial culture from tumors and various organs and tumor or organ colony formation after i.v. or i.p. injection. Selective tumor targeting was most effective with i.p. administration. The results of the present study show S. typhimurium A1-R has promising clinical potential for disseminated ovarian cancer, especially via i.p. administration.

Original languageEnglish
Pages (from-to)11369-11377
Number of pages9
JournalOncotarget
Volume6
Issue number13
DOIs
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Salmonella typhimurium
Nude Mice
Ovarian Neoplasms
Survival
Neoplasms
Intraperitoneal Injections
Poisons
Therapeutics
Intravenous Injections
Cell Line
Control Groups

Keywords

  • Bacterial therapy
  • Mouse model
  • Orthotopic
  • Ovarian cancer
  • Salmonella typhimurium A1-R

ASJC Scopus subject areas

  • Oncology

Cite this

Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice. / Matsumoto, Yasunori; Miwa, Shinji; Zhang, Yong; Zhao, Ming; Yano, Shuuya; Uehara, Fuminari; Yamamoto, Mako; Hiroshima, Yukihiko; Toneri, Makoto; Bouvet, Michael; Matsubara, Hisahiro; Tsuchiya, Hiroyuki; Hoffman, Robert M.

In: Oncotarget, Vol. 6, No. 13, 01.01.2015, p. 11369-11377.

Research output: Contribution to journalArticle

Matsumoto, Y, Miwa, S, Zhang, Y, Zhao, M, Yano, S, Uehara, F, Yamamoto, M, Hiroshima, Y, Toneri, M, Bouvet, M, Matsubara, H, Tsuchiya, H & Hoffman, RM 2015, 'Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice', Oncotarget, vol. 6, no. 13, pp. 11369-11377. https://doi.org/10.18632/oncotarget.3607
Matsumoto, Yasunori ; Miwa, Shinji ; Zhang, Yong ; Zhao, Ming ; Yano, Shuuya ; Uehara, Fuminari ; Yamamoto, Mako ; Hiroshima, Yukihiko ; Toneri, Makoto ; Bouvet, Michael ; Matsubara, Hisahiro ; Tsuchiya, Hiroyuki ; Hoffman, Robert M. / Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice. In: Oncotarget. 2015 ; Vol. 6, No. 13. pp. 11369-11377.
@article{929b06fa159c4b018fe61f243882a005,
title = "Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice",
abstract = "Peritoneal disseminated cancer is highly treatment resistant. We here report the efficacy of intraperitoneal (i.p.) administration of tumor-targeting Salmonella typhimurium A1-R in a nude mouse model of disseminated human ovarian cancer. The mouse model was established by intraperitoneal injection of the human ovarian cancer cell line SKOV3-GFP. Seven days after implantation, mice were treated with S. typhimurium A1-R via intravenous (i.v.) or i.p. administration at the same dose, 5×107 CFU, once per week. Both i.v. and i.p. treatments effected prolonged survival compared with the untreated control group (P=0.025 and P<0.001, respectively). However, i.p. treatment was less toxic than i.v. treatment. Tumor-specific targeting of S. typhimurium A1-R was confirmed with bacterial culture from tumors and various organs and tumor or organ colony formation after i.v. or i.p. injection. Selective tumor targeting was most effective with i.p. administration. The results of the present study show S. typhimurium A1-R has promising clinical potential for disseminated ovarian cancer, especially via i.p. administration.",
keywords = "Bacterial therapy, Mouse model, Orthotopic, Ovarian cancer, Salmonella typhimurium A1-R",
author = "Yasunori Matsumoto and Shinji Miwa and Yong Zhang and Ming Zhao and Shuuya Yano and Fuminari Uehara and Mako Yamamoto and Yukihiko Hiroshima and Makoto Toneri and Michael Bouvet and Hisahiro Matsubara and Hiroyuki Tsuchiya and Hoffman, {Robert M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.18632/oncotarget.3607",
language = "English",
volume = "6",
pages = "11369--11377",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "13",

}

TY - JOUR

T1 - Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice

AU - Matsumoto, Yasunori

AU - Miwa, Shinji

AU - Zhang, Yong

AU - Zhao, Ming

AU - Yano, Shuuya

AU - Uehara, Fuminari

AU - Yamamoto, Mako

AU - Hiroshima, Yukihiko

AU - Toneri, Makoto

AU - Bouvet, Michael

AU - Matsubara, Hisahiro

AU - Tsuchiya, Hiroyuki

AU - Hoffman, Robert M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Peritoneal disseminated cancer is highly treatment resistant. We here report the efficacy of intraperitoneal (i.p.) administration of tumor-targeting Salmonella typhimurium A1-R in a nude mouse model of disseminated human ovarian cancer. The mouse model was established by intraperitoneal injection of the human ovarian cancer cell line SKOV3-GFP. Seven days after implantation, mice were treated with S. typhimurium A1-R via intravenous (i.v.) or i.p. administration at the same dose, 5×107 CFU, once per week. Both i.v. and i.p. treatments effected prolonged survival compared with the untreated control group (P=0.025 and P<0.001, respectively). However, i.p. treatment was less toxic than i.v. treatment. Tumor-specific targeting of S. typhimurium A1-R was confirmed with bacterial culture from tumors and various organs and tumor or organ colony formation after i.v. or i.p. injection. Selective tumor targeting was most effective with i.p. administration. The results of the present study show S. typhimurium A1-R has promising clinical potential for disseminated ovarian cancer, especially via i.p. administration.

AB - Peritoneal disseminated cancer is highly treatment resistant. We here report the efficacy of intraperitoneal (i.p.) administration of tumor-targeting Salmonella typhimurium A1-R in a nude mouse model of disseminated human ovarian cancer. The mouse model was established by intraperitoneal injection of the human ovarian cancer cell line SKOV3-GFP. Seven days after implantation, mice were treated with S. typhimurium A1-R via intravenous (i.v.) or i.p. administration at the same dose, 5×107 CFU, once per week. Both i.v. and i.p. treatments effected prolonged survival compared with the untreated control group (P=0.025 and P<0.001, respectively). However, i.p. treatment was less toxic than i.v. treatment. Tumor-specific targeting of S. typhimurium A1-R was confirmed with bacterial culture from tumors and various organs and tumor or organ colony formation after i.v. or i.p. injection. Selective tumor targeting was most effective with i.p. administration. The results of the present study show S. typhimurium A1-R has promising clinical potential for disseminated ovarian cancer, especially via i.p. administration.

KW - Bacterial therapy

KW - Mouse model

KW - Orthotopic

KW - Ovarian cancer

KW - Salmonella typhimurium A1-R

UR - http://www.scopus.com/inward/record.url?scp=84929649278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929649278&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.3607

DO - 10.18632/oncotarget.3607

M3 - Article

VL - 6

SP - 11369

EP - 11377

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 13

ER -